Papers: 10.1136/jitc-2020-001901

https://doi.org/10.1136/jitc-2020-001901

Considerations for treatment duration in responders to immune checkpoint inhibitors

Cited by: 59
Author(s): Thomas U. Marron, Aideen E. Ryan, Sangeetha M. Reddy, Sabina Kaczanowska, Rania H. Younis, Dipti Thakkar, Jiajia Zhang, Todd Bartkowiak, Rachel Howard, Kristin G. Anderson, Daniel J. Olson, Abdul Rafeh Naqash, Ravi B. Patel, Esha Sachdev, María E. Rodríguez-Ruiz, Michal Sheffer, S. Church, Christopher A. Fuhrman, Abigail Overacre-Delgoffe, Rosa Nguyen, Vaia Florou, Jessica E. Thaxton, David H. Aggen, Jennifer L. Guerriero
Published: over 5 years ago

Software Mentions 1